Pancreatic surgery

Current Opinion in Gastroenterology

Volumn 26, Issue 5, 2010, Pages 499-505

  Donahue, Timothy R ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute pancreatitis; chronic pancreatitis; delayed gastric emptying; distal pancreatectomy; neoplastic pancreatic cysts; pancreatic cancer; pancreatic fistula; pancreatic pseudocysts; pancreaticoduodenectomy

Indexed keywords

CHOLECYSTECTOMY; CLINICAL TRIAL; CYST FLUID; DIAGNOSTIC ACCURACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GALLSTONE; GENETIC MARKER; HUMAN; MORBIDITY; MORTALITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS PSEUDOCYST; PANCREAS SURGERY; PANCREATITIS; PERIOPERATIVE PERIOD; REVIEW;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATECTOMY; PANCREATIC DISEASES; TREATMENT OUTCOME;

EID: 77955922223     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32833d1174     Document Type: Review

References (34)

1. Johnson MD, Walsh RM, Henderson JM, et al. Surgical versus nonsurgical management of pancreatic pseudocysts. J Clin Gastroenterol 2009; 43:586-590.
2. Pedrazzoli S, Liessi G, Pasquali C, et al. Postoperative pancreatic fistulas: preventing severe complications and reducing reoperation and mortality rate. Ann Surg 2009; 249:97-104.
3. Kendrick ML, Cusati D. Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg 2010; 145:19-23.
4. Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol 2009; 16:1725-1726.
5. Bilimoria KY, Bentrem DJ, Lillemoe KD, et al. Pancreatic Cancer Quality Indicator Development Expert Panel ACoS. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst 2009; 101:848-859; PMCID: PMC2697207.
6. van Santvoort HC, Besselink MG, de Vries AC, et al. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg 2009; 250:68-75.
7. Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg 2010; 251:615-619.
8. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128:586-590.
9. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6 (1-2):17-32.
10. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg 2009; 144:448-454.
11. Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markovbased clinical nomograms. Gastroenterology 2010; 138:531-540.
12. Grobmyer SR, Cance WG, Copeland EM, et al. Is there an indication for initial conservative management of pancreatic cystic lesions? J Surg Oncol 2009; 100:372-374.
13. Ceppa EP, De la Fuente SG, Reddy SK, et al. Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter? J Gastrointest Surg 2010; 14:236-244.
14. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126:1330-1336.
15. Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69:1095-1102.
16. Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009; 16:1727-1733.
17. Choti MA, Dixon E, Tyler D. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al. Ann Surg Oncol 2009; 16:1734-1735.
18. Evans DB, FarnellMB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 2009; 16:1736-1744.
19. Abrams RA, Lowy AM, O'Reilly EM, et al. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 2009; 16:1751-1756.
20. Berlin J, Hoffman JP, Regine WF. Editorial: Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus conference. Ann Surg Oncol 2009; 16:1757-1759; PMCID: PMC2695869.
21. Barton JG, Bois JP, Sarr MG, et al. Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg 2009; 13:2050-2058.
22. Turrini O, Schmidt CM, Moreno J, et al. Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy? J Gastrointest Surg 2009; 13:1791-1797.
23. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129-137.
24. Mezhir JJ, Brennan MF, Baser RE, et al. A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified. J Gastrointest Surg 2009; 13:2163-2169.
25. Hernandez J, Mullinax J, Clark W, et al. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 2009; 250:76-80.
26. DillhoffM, Yates R, Wall K, et al. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg 2009; 13:825-830.
27. Fatima J, Schnelldorfer T, Barton J, et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:167-172.
28. Nathan H, Cameron JL, Goodwin CR, et al. Risk factors for pancreatic leak after distal pancreatectomy. Ann Surg 2009; 250:277-281.
29. Yamamoto M, Hayashi MS, Nguyen NT, et al. Use of Seamguard to prevent pancreatic leak following distal pancreatectomy. Arch Surg 2009; 144:894-899.
30. Hawkins WG. To mesh or not to mesh, that is the question: comment on 'Use of Seamguard to prevent pancreatic leak following distal pancreatectomy'. Arch Surg 2009; 144:899.
31. Shukla PJ, Barreto SG, Fingerhut A, et al. Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2009; 147:144-153.
32. Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery 2010; 146:503-515.
33. Teh SH, Diggs BS, Deveney CW, Sheppard BC. Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volumebased referral guidelines. Arch Surg 2009; 144:713-721.
34. Eppsteiner RW, Csikesz NG, McPhee JT, et al. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg 2009; 249:635-640.